{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T17:09:43Z","timestamp":1768583383705,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":1741,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1038\/mt.2011.210","type":"journal-article","created":{"date-parts":[[2011,10,11]],"date-time":"2011-10-11T17:40:47Z","timestamp":1318354847000},"page":"91-100","source":"Crossref","is-referenced-by-count":36,"title":["Delivery of siRNA to the Mouse Lung via a Functionalized Lipopolyamine"],"prefix":"10.1016","volume":"20","author":[{"given":"Kevin J","family":"Polach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majed","family":"Matar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Rice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Slobodkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff","family":"Sparks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Congo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Rea-Ramsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"McClure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine","family":"Brunhoeber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Krampert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Jahn-Hofmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"John","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Peter","family":"Vornlocher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason G","family":"Fewell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khursheed","family":"Anwer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anke","family":"Geick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2011.210_bib1","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/emmm.200900023","article-title":"RNAi-based therapeutics-current status, challenges and prospects","volume":"1","author":"Tiemann","year":"2009","journal-title":"EMBO Mol Med"},{"key":"10.1038\/mt.2011.210_bib2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.addr.2009.05.002","article-title":"Small silencing RNAs: state-of-the-art","volume":"61","author":"Grimm","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1038\/mt.2011.210_bib3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1758-907X-1-14","article-title":"A status report on RNAi therapeutics","volume":"1","author":"Vaishnaw","year":"2010","journal-title":"Silence"},{"key":"10.1038\/mt.2011.210_bib4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature03121","article-title":"Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs","volume":"432","author":"Soutschek","year":"2004","journal-title":"Nature"},{"key":"10.1038\/mt.2011.210_bib5","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1172\/JCI33494","article-title":"Nonviral delivery of synthetic siRNAs in vivo","volume":"117","author":"Akhtar","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2011.210_bib6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/156720107782151269","article-title":"Liposomal drug delivery systems: an update review","volume":"4","author":"Samad","year":"2007","journal-title":"Curr Drug Deliv"},{"key":"10.1038\/mt.2011.210_bib7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nbt1402","article-title":"A combinatorial library of lipid-like materials for delivery of RNAi therapeutics","volume":"26","author":"Akinc","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2011.210_bib8","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1517\/17425247.5.9.927","article-title":"Nanotechnology for drug delivery: the perfect partnership","volume":"5","author":"Farokhzad","year":"2008","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1038\/mt.2011.210_bib9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.mt.6300323","article-title":"Tumor-targeted delivery of siRNA by self-assembled nanoparticles","volume":"16","author":"Li","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.210_bib10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.nurt.2009.01.018","article-title":"Nanotechnology for delivery of drugs to the brain for epilepsy","volume":"6","author":"Bennewitz","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1038\/mt.2011.210_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1021\/nn900002m","article-title":"Impact of nanotechnology on drug delivery","volume":"3","author":"Farokhzad","year":"2009","journal-title":"ACS Nano"},{"key":"10.1038\/mt.2011.210_bib12","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1021\/mp800134q","article-title":"Nonviral methods for siRNA delivery","volume":"6","author":"Gao","year":"2009","journal-title":"Mol Pharm"},{"key":"10.1038\/mt.2011.210_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.nano.2008.06.001","article-title":"Drug delivery of siRNA therapeutics: potentials and limits of nanosystems","volume":"5","author":"Reischl","year":"2009","journal-title":"Nanomedicine"},{"key":"10.1038\/mt.2011.210_bib14","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.addr.2009.03.003","article-title":"Lipid-based systemic delivery of siRNA","volume":"61","author":"Tseng","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1038\/mt.2011.210_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrd2742","article-title":"Knocking down barriers: advances in siRNA delivery","volume":"8","author":"Whitehead","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1038\/mt.2011.210_bib16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2165\/11534450-000000000-00000","article-title":"Strategies for in vivo delivery of siRNAs: recent progress","volume":"24","author":"Higuchi","year":"2010","journal-title":"BioDrugs"},{"key":"10.1038\/mt.2011.210_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2796.2009.02189.x","article-title":"Lipid-based nanotherapeutics for siRNA delivery","volume":"267","author":"Schroeder","year":"2010","journal-title":"J Intern Med"},{"key":"10.1038\/mt.2011.210_bib18","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nbt.1602","article-title":"Rational design of cationic lipids for siRNA delivery","volume":"28","author":"Semple","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2011.210_bib19","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/mt.2009.36","article-title":"Development of lipidoid-siRNA formulations for systemic delivery to the liver","volume":"17","author":"Akinc","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.210_bib20","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/sj.gt.3302777","article-title":"A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium","volume":"13","author":"Santel","year":"2006","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2011.210_bib21","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1021\/mp900093r","article-title":"Biological barriers to therapy with antisense and siRNA oligonucleotides","volume":"6","author":"Juliano","year":"2009","journal-title":"Mol Pharm"},{"key":"10.1038\/mt.2011.210_bib22","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ymthe.2006.01.001","article-title":"Progress towards in vivo use of siRNAs","volume":"13","author":"Behlke","year":"2006","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.210_bib23","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/sj.gt.3302778","article-title":"RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy","volume":"13","author":"Santel","year":"2006","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2011.210_bib24","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature08956","article-title":"Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles","volume":"464","author":"Davis","year":"2010","journal-title":"Nature"},{"key":"10.1038\/mt.2011.210_bib25","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/mt.2010.85","article-title":"Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms","volume":"18","author":"Akinc","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.210_bib26","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0021-9258(19)85022-6","article-title":"Effects of apolipoproteins A-IV and A-I on the uptake of phospholipid liposomes by hepatocytes","volume":"264","author":"Bisgaier","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2011.210_bib27","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1073\/pnas.0910603106","article-title":"Lipid-like materials for low-dose, in vivo gene silencing","volume":"107","author":"Love","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2011.210_bib28","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1038\/mt.2010.147","article-title":"Noninvasive imaging of lipid nanoparticle-mediated systemic delivery of small-interfering RNA to the liver","volume":"18","author":"Tao","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.210_bib29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/mp800051m","article-title":"Factors affecting the clearance and biodistribution of polymeric nanoparticles","volume":"5","author":"Alexis","year":"2008","journal-title":"Mol Pharm"},{"key":"10.1038\/mt.2011.210_bib30","first-page":"297","article-title":"Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential","volume":"1","author":"Immordino","year":"2006","journal-title":"Int J Nanomedicine"},{"key":"10.1038\/mt.2011.210_bib31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-5793(90)81016-H","article-title":"Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes","volume":"268","author":"Klibanov","year":"1990","journal-title":"FEBS Lett"},{"key":"10.1038\/mt.2011.210_bib32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1089\/oli.2009.0180","article-title":"siRNA and innate immunity","volume":"19","author":"Robbins","year":"2009","journal-title":"Oligonucleotides"},{"key":"10.1038\/mt.2011.210_bib33","doi-asserted-by":"crossref","first-page":"L350","DOI":"10.1152\/ajplung.00061.2004","article-title":"CCR2-positive monocytes recruited to inflamed lungs downregulate local CCL2 chemokine levels","volume":"288","author":"Maus","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1038\/mt.2011.210_bib34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1165\/rcmb.2005-0239OC","article-title":"The role of CCL12 in the recruitment of fibrocytes and lung fibrosis","volume":"35","author":"Moore","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1038\/mt.2011.210_bib35","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.4049\/jimmunol.0901316","article-title":"The CCL7-CCL2-CCR2 axis regulates IL-4 production in lungs and fungal immunity","volume":"183","author":"Szymczak","year":"2009","journal-title":"J Immunol"},{"key":"10.1038\/mt.2011.210_bib36","doi-asserted-by":"crossref","first-page":"e491","DOI":"10.1371\/journal.pmed.0030491","article-title":"Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus","volume":"3","author":"Bauer","year":"2006","journal-title":"PLoS Med"},{"key":"10.1038\/mt.2011.210_bib37","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.2353\/ajpath.2009.090328","article-title":"Type I interferon modulates monocyte recruitment and maturation in chronic inflammation","volume":"175","author":"Lee","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1038\/mt.2011.210_bib38","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ymthe.2005.11.002","article-title":"Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo","volume":"13","author":"Judge","year":"2006","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.210_bib39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jconrel.2010.12.017","article-title":"Comparative in vivo study of poly(ethylene imine)\/siRNA complexes for pulmonary delivery in mice","volume":"151","author":"Beyerle","year":"2011","journal-title":"J Control Release"},{"key":"10.1038\/mt.2011.210_bib40","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/oli.2010.0235","article-title":"Efficient gene silencing in lungs and liver using imidazole-modified chitosan as a nanocarrier for small interfering RNA","volume":"20","author":"Ghosn","year":"2010","journal-title":"Oligonucleotides"},{"key":"10.1038\/mt.2011.210_bib41","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ejpb.2010.11.007","article-title":"Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung","volume":"77","author":"G\u00fcnther","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1038\/mt.2011.210_bib42","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1021\/mp100101s","article-title":"Triazine dendrimers as nonviral vectors for in vitro and in vivo RNAi: the effects of peripheral groups and core structure on biological activity","volume":"7","author":"Merkel","year":"2010","journal-title":"Mol Pharm"},{"key":"10.1038\/mt.2011.210_bib43","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ejpb.2010.11.016","article-title":"Gene silencing activity of siRNA polyplexes based on biodegradable polymers","volume":"77","author":"Varkouhi","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1038\/mt.2011.210_bib44","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s11095-008-9755-4","article-title":"Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug","volume":"26","author":"Garbuzenko","year":"2009","journal-title":"Pharm Res"},{"key":"10.1038\/mt.2011.210_bib45","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.pupt.2010.03.007","article-title":"RNAi-mediated suppression of constitutive pulmonary gene expression by small interfering RNA in mice","volume":"23","author":"Gutbier","year":"2010","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1038\/mt.2011.210_bib46","doi-asserted-by":"crossref","first-page":"10737","DOI":"10.1073\/pnas.1004604107","article-title":"Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance","volume":"107","author":"Garbuzenko","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2011.210_bib47","first-page":"81","article-title":"Oligoribonucleotide synthesis. The silyl-phosphoramidite method","volume":"20","author":"Damha","year":"1993","journal-title":"Methods Mol Biol"},{"key":"10.1038\/mt.2011.210_bib48","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1093\/nar\/18.10.2855","article-title":"Abasic oligodeoxyribonucleoside phosphorothioates: synthesis and evaluation as anti-HIV-1 agents","volume":"18","author":"Iyer","year":"1990","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mt.2011.210_bib49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/gene.1030","article-title":"Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line","volume":"30","author":"Constien","year":"2001","journal-title":"Genesis"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616304543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616304543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T03:29:28Z","timestamp":1639106968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616304543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1525001616304543"],"URL":"https:\/\/doi.org\/10.1038\/mt.2011.210","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}